Applications of (R)-N-(Tert-Butoxycarbonyl)-2-Phenylglycinol in Industrial Manufacturing

(R)-N-(Tert-Butoxycarbonyl)-2-Phenylglycinol supports critical chiral and protection chemistry across diverse manufacturing streams. As an established intermediate, it plays a core role in complex molecule assembly within regulated and high-purity frameworks. The following industrial application sections highlight our direct experience servicing downstream processors in tightly defined fields.

1. Chiral Intermediate for Active Pharmaceutical Ingredient Synthesis

Pharmaceutical manufacturers rely on this compound as a stereo-selective building block for chiral APIs, particularly in the synthesis of β-amino alcohol frameworks and optically pure amines. The protected amino alcohol enables precise introduction and later removal of the Boc-group during multi-step routes for antihypertensive agents, CNS actives, and oncology molecules. We support API customers through extensive batch documentation and tailored purity controls, adjusting the specification to fit both small molecule synthesis and scale-up under differentiation of crude, intermediate, and final isolation.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredient Manufacturing
• USP <791>, <621>, <467> (Identification, Chromatography, Residual Solvents)
• 21 CFR Part 210/211 for US drug intermediates
• ICH Q3C Impurities Guideline

Typical usage ratio

• 0.8–1.3 equivalents in chiral building block formation, optimized per target chiral center and process yield requirements
• Stoichiometry adjusted according to downstream purification efficiency and desired enantiomeric excess

Downstream process integration

• Enters at initial condensation or amidation step
• Protection group enables selective functionalization sequences
• Removed via acidolysis at penultimate or final step
• Facilitates chiral resolution and scale-up of intermediates

Final product types

• β-blockers, e.g., Nebivolol intermediates
• Selective serotonin reuptake inhibitors and related CNS molecules
• Oncology research compounds featuring optically pure side chains
• Regulated GMP intermediates for site-specific pharmaceutical manufacturing

2. Intermediate for Peptide and Peptidomimetic Synthesis

Specialty peptide companies utilize (R)-protected 2-phenylglycinol to introduce chiral auxiliaries into modified peptide chains and small bioactive macrocycles. The Boc-protected structure serves as a temporary nitrogen protection group, enabling selective amide bond formation in liquid-phase and solid-phase peptide synthesis (SPPS). Customers validate input quality through amino acid analysis and trace-metal reporting, demanding batch consistency and controlled optical purity to minimize sequence scrambling and guarantee high-yield cyclization.

Industry compliance standards

• GMP guidelines for the production of pharmaceutical peptides (ICH Q7, FDA Guidance for Peptides)
• Ph. Eur. 2.2.56 (Amino Acid Analysis)
• USP <1047> for peptide quality control
• ISO 9001 for ingredient traceability

Typical usage ratio

• 0.9–1.1 molar equivalents per protected amino group inserted
• Adjusted for chain length and peptide complexity
• Excess minimized to improve purification and resin cleavage efficiency

Downstream process integration

• Pre-coupled to carboxy terminal during orthogonal protection steps
• Participates in on-resin coupling in SPPS workflows
• Boc-group cleaved during final global deprotection
• Allows discrimination in ring-closing or head-to-tail cyclizations

Final product types

• Peptidomimetic drugs and lead compounds
• Small peptide hormone analogues
• Bioactive macrocyclic peptides for research screening
• Cyclic peptide intermediates for further bioconjugation

3. Building Block for Chiral Ligand and Catalyst Manufacturing

Chemical manufacturers specialized in asymmetric catalysis incorporate this material into the preparation of tailored chiral ligands and catalysts. The ability to introduce a defined stereocenter—protected and then de-protected as required—makes it suitable for assembling phosphine, oxazoline, and amino alcohol-based ligand backbones. Downstream process chemists optimize the introduction point for efficiency, focusing on reproducibility and high enantiopurity during Grignard reactions or subsequent metal complexation steps essential for producing homogeneous catalysts.

Industry compliance standards

• ISO 9001-certified QMS for specialty reagents
• REACH Annex IV registration (Europe) for catalyst chemicals
• Purity and optical rotation as per internal QC procedures
• Internal hazardous reagent handling SOPs

Typical usage ratio

• 0.95–1.2 molar equivalents per chiral ligand backbone
• Ratio tailored per specific ligand scaffold
• Batch scale adapted to catalyst throughput needs

Downstream process integration

• Introduced at ligand assembly stage via substitution or addition reactions
• Boc-protection enables compatibility with sensitive organometallic steps
• Protection removed before final catalyst activation or metal insertion
• QC oversights at each transformation stage for chiral purity

Final product types

• Chiral phosphine and phosphoramidite ligands
• Metal-organic catalysts for asymmetric hydrogenation
• Ligand intermediates for specialty fine chemical manufacture
• Enantioselective catalyst toolkits for academic and commercial R&D

4. Intermediate for Agrochemical Stereoisomer Synthesis

Agrochemical synthesis routes increasingly demand chiral intermediates to enhance selectivity and reduce regulatory risk of racemic mixtures. Our manufacturing customers in this sector introduce this protected chiral amino alcohol to assemble optically active intermediates for herbicide and fungicide actives. The Boc group provides robust protection during functional group modifications and selective deprotection allows for downstream resolution or derivatization, supporting both high-throughput screening and full-scale active ingredient production.

Industry compliance standards

• ISO 14001/9001 for chemical manufacture under environmental and quality frameworks
• REACH Registration (EU) for agricultural intermediates
• Integrated pest management (IPM) input documentation
• Occupational health and safety (OHSAS 18001 or ISO 45001) practices

Typical usage ratio

• 1.0 equivalent at chiral center introduction points
• Adjusted by active ingredient’s structural complexity
• Process optimized for stereochemical yield versus downstream enrichment efficiencies

Downstream process integration

• Used during stereospecific imine or alcohol modifications
• Boc-protection streamlines subsequent nucleophilic and electrophilic reactions
• Deprotection in final or penultimate build-up steps
• Monitored for consistent optical purity in every lot

Final product types

• Chiral intermediates for selective herbicide actives
• Optically pure fungicide precursors
• Stereospecific adjuvant building blocks
• R&D reference standards for agrochemical screening